Global Health Ltd (MEDANTA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Global Health Ltd on NSE and BSE, with an AI summary of each filing.
Intimation under Regulation 30 of SEBI Listing regulations, 2015 - Audio Recording.
Audio / Video · 04 Nov 2026, 10:21 pm
Global Health Releases Q2 & H1 FY27 Earnings Call Audio Recording Global Health Limited (MEDANTA) has released the audio recording of its earnings conference call held on 4th Nov'26. The call, hosted by Investec Capital Services (India) Private Limited, discussed the company's financial results for the second quarter and half year ended 30th Sep'26. The recording has been made available on the company's investor relations portal pursuant to Regulation 30 of SEBI Listing Regulations.
Investor Presentation for the Second Quarter and Half Year ended September 30, 2026, Results.
Investor Presentation · 03 Nov 2026, 10:51 pm
Global Health Delivers Strong Q2 FY27 Growth Driven by Patient Volumes and Noida Breakeven Global Health reported robust Q2 FY27 performance, with revenue from operations rising 33.6% YoY to INR 14,690 mn and operating EBITDA surging 60.2% YoY to INR 3,701 mn, expanding margins 418 bps to 25.2%. PAT grew 38.3% YoY to INR 2,191 mn. Operational momentum was underpinned by strong volume growth, with IPD and OPD volumes up 29.5% and 37.9% YoY, respectively, alongside Noida achieving EBITDA breakeven at INR 86 mn. As of 30th Sep'26, net cash stood at INR 7,815 mn, supporting a ~INR 62,390 mn expansion pipeline.
Press Release for the Second Quarter and Half Year ended on September 30, 2026 Results.
Press Release · 03 Nov 2026, 10:45 pm
Global Health Delivers Strong Q2 FY27 With 60% EBITDA Growth Global Health (Medanta) reported robust Q2 FY27 results, with revenue from operations rising 33.6% YoY to INR 14,690 million and operating EBITDA jumping 60.2% YoY to INR 3,701 million as margins expanded 418 bps to 25.2%. PAT grew 38.3% YoY to INR 2,191 million. Operational beds reached 3,115 with 67% occupancy, driven by inpatient volume growth of 29.5% YoY. Noida hospital achieved EBITDA breakeven at INR 86 million. The board approved a new 500-bed greenfield hospital in Ghaziabad with an estimated capex of ~INR 9,970 million.
Announcement under Regulation 30 of Listing Regulations for capacity addition at proposed Hospital in Ghaziabad.
Others (Uncategorized) · 03 Nov 2026, 9:49 pm
Medanta Q2 Results and ₹997 Crore Ghaziabad Hospital Expansion Approval Global Health approved Q2 results for the period ended 30th Sep'26, reporting consolidated revenue from operations of ₹14,690.43M, up 33.6% YoY and 12.6% QoQ. Consolidated profit after tax reached ₹2,191.44M, increasing 38.3% YoY and 39.4% QoQ, with basic EPS rising to ₹8.21. Additionally, the board approved a ₹997 crore project budget, including ₹165.82 crore for land, to develop a 500-bed multi-specialty hospital in Ghaziabad, Uttar Pradesh, expanding capacity beyond its existing 3,811 beds over the next 3–4 years via internal accruals and debt.
Results for the Quarter and Half Year ended September 30, 2026
Financial Result · 03 Nov 2026, 9:41 pm
Global Health Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 03 Nov 2026, 9:36 pm
Outcome of Board Meeting held on November 03, 2026, to consider and approved the unaudited financial Results for the Quarter & Half year ended September 30, 2026.
Outcome · 03 Nov 2026, 9:33 pm
Global Health Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 14,690 (+33.6% YoY | +12.7% QoQ) ■ EBITDA: 3,701 (+60.2% YoY | +29.1% QoQ) ■ EBITDA Margin (%): 25.2 (+418 bps YoY | +320 bps QoQ) ■ PAT: 2,207 (+39.3% YoY | +39.0% QoQ) ■ EPS (INR): 8.20 (+39.2% YoY | +39.0% QoQ)
Announcement Regarding Change in Management
Change in Management · 02 Nov 2026, 10:59 pm
Global Health Approves 3.14 Lakh ESOPs and Notes HR Head Resignation Global Health Limited's Nomination and Remuneration Committee approved the grant of 3,14,000 ESOPs to 45 eligible employees under the GHL LTIP 2024 Plan at an exercise price of Rs. 635 per share on 2nd Nov'26. The options carry a maximum vesting period of five years and an exercise window of three years post-final vesting. Concurrently, the committee noted the resignation of Saurabh Upadhyay, Senior Vice President & Head-HR and Senior Management Personnel, whose last working day will be 23rd Dec'26.
It is informed that Nomination and Remuneration Committee in its Meeting held today i.e November 02, 2026, has made a grant of 3,14,000 ESOPs under GHL LTIP 2024.
Others (Uncategorized) · 02 Nov 2026, 10:54 pm
Global Health Approves 3.14 Lakh ESOPs and Announces Senior Management Resignation Global Health Limited's Nomination and Remuneration Committee approved the grant of 3,14,000 ESOPs to 45 eligible employees under the GHL LTIP 2024 Plan at an exercise price of Rs. 635 per share on 2nd Nov'26. The options carry a maximum vesting period of 5 years and an exercise period of up to 3 years post final vesting. Additionally, the company noted the resignation of Saurabh Upadhyay, Senior VP & Head-HR (Senior Management Personnel), effective from the close of business hours on 23rd Dec'26.
Announcement regarding Change in Management.
Change in Management · 31 Oct 2026, 10:34 pm
Global Health Announces Resignation of Gurugram Hospital Director Global Health Limited announced the resignation of Dr. Pankaj Dhamija, Hospital Director for its Gurugram Unit and Senior Management Personnel, effective close of business on 30th Oct'26. Dr. Dhamija resigned on 21st Sep'26 to pursue outside opportunities, with the resignation accepted on 26th Sep'26. While his contractual notice period ran until 21st Dec'26, the company relieved him early on 30th Oct'26 after noting his plans to join a competitor.
Announcement under SEBI Listing Regulation regarding schedule of Institutional investor meet.
Intimation · 04 Nov 2026, 2:00 pm
Global Health Limited Schedules Q2 FY2027 Earnings Conference Call Global Health Limited (Medanta) will host its Q2 and H1 FY2027 earnings conference call on 4th Nov'26 at 2:00 PM IST, hosted by Investec Capital Services. Senior leadership, including CMD Dr. Naresh Trehan, Group CEO Pankaj Sahni, and CFO Yogesh Kumar Gupta, will represent the company. Medanta operates six hospitals with 3,737 installed beds across 5.6 million sq. ft. as of 30th Jun'26, alongside seven planned hospital additions across Mumbai, Guwahati, Varanasi, and Delhi NCR.
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding allotment of Shares.
Others (Uncategorized) · 23 Oct 2026, 11:22 pm
Global Health Approves ESOP Share Allotment Global Health Limited's Nomination & Remuneration Committee approved the allotment of 2,750 equity shares (face value Rs. 2 each) at an issue price of Rs. 1,233 per share (including a premium of Rs. 1,231) on 23rd Oct'26 under its GHL LTIP 2024 Plan. Following the allotment to the ESOP Trust, the company’s paid-up share capital increased from Rs. 53.77 cr (26,88,74,782 shares) to Rs. 53.78 cr (26,88,77,532 shares). The newly allotted shares rank pari-passu with existing equity shares.
GLOBAL HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 03 Nov 2026, 5:30 am
Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Global Health Limited has informed ....
Intimation · 03 Nov 2026, 5:30 am
Global Health Limited Schedules Board Meeting for Q2 and H1 FY27 Results Global Health Limited (MEDANTA) will hold a Board of Directors meeting on 3rd Nov'26 to consider and approve the unaudited financial results for the second quarter and half year ended 30th Sep'26. In compliance with insider trading regulations, the company's trading window closed on 1st Oct'26 and will reopen 48 hours after the declaration of the financial results.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 03 Nov 2026, 5:30 am
Intimation Under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015 - ESG Rating assigned by Crisil ESG Ratings & Analytics Limited.
Others (Uncategorized) · 05 Oct 2026, 6:51 pm
Global Health Assigned FY26 ESG Ratings by CRISIL Global Health Limited (Medanta) received its FY26 ESG evaluation from CRISIL ESG Ratings & Analytics Limited. The rating agency assigned an overall rating of 'CRISIL ESG 64' alongside a 'CRISIL Core ESG 70' rating to the company. The official communication was received post-market hours on 1st Oct'26 and subsequently disclosed to stock exchanges on 5th Oct'26 following the holiday weekend.
Medanta to expand Healthcare Footprint in Uttar Pradesh with the Acquisition of 10,560 Sq. Meter Land Parcel in Ghaziabad.
Press Release · 29 Sept 2026, 5:37 pm
Medanta Acquires Ghaziabad Land Parcel for ₹165.8 Crore to Build 350+ Bed Hospital Global Health Limited (Medanta) was allotted a 10,560 sq. metre freehold land parcel at Siddharth Vihar Yojna, Ghaziabad, Uttar Pradesh, for ~₹165.82 crore via an online auction by UPAVP on 29th Sep'26. The site will house a planned 350+ bed hospital subject to board and statutory approvals, expanding Medanta's footprint across Delhi-NCR alongside its operational Noida facility. As of 30th Jun'26, Medanta operates 3,737 beds across six hospitals with five other facilities underway in Mumbai, Delhi, Guwahati, and Varanasi.
Intimation Under Regulation 30 of Listing Regulations.
Others (Uncategorized) · 28 Sept 2026, 7:07 pm
Global Health Acquires Land in Ghaziabad for Rs 165.82 Crore to Build Hospital Global Health Limited (Medanta) secured a freehold land parcel measuring 10,560.36 sq. meters via an online auction by UPAVP for approximately Rs 165.82 crore. Located at Siddharth Vihar Yojna, Ghaziabad, Uttar Pradesh, the site can accommodate a 350+ bed hospital, subject to statutory approvals. Management is currently evaluating next steps and preparing a detailed project plan for board approval. The formal allotment letter, dated 26th Sep'26, was received by the company on 28th Sep'26.
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
Intimation · 22 Sept 2026, 10:29 pm
Global Health Schedules Institutional Investor Meeting with Arohi Asset Management Global Health Limited (MEDANTA) has scheduled a one-on-one virtual meeting between company management and Arohi Asset Management (India) Private Limited on 25th Sep'26. The meeting will be conducted virtually pursuant to Regulation 30 of SEBI Listing Regulations, with the company confirming that no Unpublished Price Sensitive Information (UPSI) will be shared.
Intimation under Regulation 30 of Listing Regulations regarding allotment of shares.
Others (Uncategorized) · 22 Sept 2026, 10:13 pm
Global Health Allots 3,000 Equity Shares Under Employee Stock Option Scheme Global Health Limited approved the allotment of 3,000 equity shares (face value Rs. 2 each) on 22nd Sep'26 under its GHL LTIP 2024 Plan to the GHL Employees Welfare Trust. The shares were issued at Rs. 1,500 per share (including a premium of Rs. 1,498 per share), while the employee exercise price stood at Rs. 2 per share. Consequently, paid-up equity capital increased marginally to Rs. 53,77,49,564 (26,88,74,782 shares), with all newly allotted shares ranking pari-passu with existing equity shares.
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
Intimation · 17 Sept 2026, 6:54 pm
Global Health Limited Schedules One-on-One Investor Meeting with USS Investment Management Global Health Limited (MEDANTA) announced that its management will participate in an in-person, one-on-one institutional investor meeting with USS Investment Management Ltd on 23rd Sep'26 in Gurugram. The company confirmed that no unpublished price-sensitive information (UPSI) will be shared during the scheduled interaction.
Enclosed Scrutinizer Report and Voting Results of 22nd Annual General Meeting of the Company.
Annual General Meeting · 16 Sept 2026, 11:51 pm
Proceeding of 22nd Annual General Meeting of the Company held on September 16, 2026, at 12:00 Noon.
Annual General Meeting · 16 Sept 2026, 9:33 pm
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
Intimation · 11 Sept 2026, 9:50 pm
Global Health Schedules Institutional Investor Meetings with Jefferies and Kotak Global Health Limited (MEDANTA) will participate in two upcoming in-person group investor conferences. Management is scheduled to attend the Jefferies India Forum 2026 in Gurugram on 17th Sep'26, followed by the Kotak Healthcare Forum 2026 in Mumbai on 18th Sep'26. The company confirmed that no unpublished price-sensitive information (UPSI) will be shared during these interactions.
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
Intimation · 11 Sept 2026, 9:47 pm
Global Health Limited Schedules Investor Meetings for Sep'26 Global Health Limited (MEDANTA) will participate in two upcoming institutional investor conferences. Management is scheduled to attend in-person group meetings at the Jefferies India Forum on 17th Sep'26 in Gurugram, followed by the Kotak Healthcare Forum on 18th Sep'26 in Mumbai. The company confirmed that no unpublished price sensitive information (UPSI) will be shared during these interactions.